King Pharmaceuticals, Inc. Credit Rating

Registrierter Nutzer

Bitte loggen Sie sich ein, um Zugang zu den für Sie freigeschalteten Bereichen zu erhalten. Bitte achten Sie bei der Eingabe des Passworts auf Groß- und Kleinschreibung.

Benutzername:

Passwort:

Automatisch einloggen, wenn ich wieder hierher zurückkehre

Benutzernamen und/oder Passwort vergessen?

Noch nicht registriert?

Jetzt registrieren für Zugriff auf:

Emittentenratings.

Ratings für über 170.000 Unternehmensschuldverschreibungen, Staatspapiere und strukturierte Finanzinstrumente.

Veranstaltungskalender.

Informationen über Schulungen, Briefings und Telefon- und Videokonferenzen.

Watchlisten.

Liste aller Emittenten, deren Ratings hinsichtlich einer eventuellen Änderung überprüft werden.

Ratingmethodiken.

Beschreibung des konzeptionellen Rahmens, der unseren Ratings zugrunde liegt.

Ergebnisse 1 - 31 von 31

Seite 1 von 1 Next

Filtern nach:

Datum	Dokument-Art	Titel	Quelle
03 Mar 2011	Announcement	Moody's withdraws ratings of King Pharmaceuticals	Moody's Investors Service
13 Oct 2010	Special Comment	Global Pharmaceutical Issuer Scorecard	Moody's Investors Service
12 Oct 2010	Announcement	Moody's reviews King Pharmaceuticals for upgrade	Moody's Investors Service
07 May 2010	LGD Assessment	King Pharmaceuticals, Inc.	Moody's Investors Service
29 Apr 2010	Credit Opinion	King Pharmaceuticals, Inc.	Moody's Investors Service
28 Apr 2010	Rating Action	Moody's assigns Ba1 to King's new credit facility; upgrades SGL	Moody's Investors Service
19 Nov 2009	Announcement	Moody's: Negativer Ausblick für die globale Pharmaindustrie	Moody's Investors Service
29 Oct 2009	LGD Assessment	King Pharmaceuticals, Inc.	Moody's Investors Service
07 Jan 2009	Rating Action	Moody's upgrades King's revolver to Ba2; Lowers SGL to SGL-2	Moody's Investors Service
25 Sep 2008	Rating Action	Moody's assigns Ba2 to King Pharmaceuticals' new credit facility	Moody's Investors Service
27 Aug 2008	LGD Assessment	King Pharmaceuticals, Inc.	Moody's Investors Service
25 Aug 2008	Announcement	Moody's affirms King Pharmaceuticals' Ba3 ratings	Moody's Investors Service
21 May 2008	Rating Action	Moody's Assigns SGL-1 Rating to King Pharmaceuticals	Moody's Investors Service
20 Nov 2007	Rating Action	Moody's Rates King Pharma's Revolver Ba3	Moody's Investors Service
28 Mar 2007	Rating Action	Moody's outlook on King Pharmaceuticals now stable	Moody's Investors Service
26 Sep 2006	LGD Assessment	King Pharmaceuticals, Inc.	Moody's Investors Service
21 Sep 2006	Rating Action	Moody's changes ratings on 9 US pharmaceutical companies under LGD rating methodology	Moody's Investors Service
22 Aug 2006	Rating Action	Moody's withdraws Ba3 rating of King Pharmaceuticals, Inc.'s 2 ¾% convertible debentures due 2021	Moody's Investors Service
23 Mar 2006	Announcement	MOODY'S AFFIRMS RATINGS OF KING PHARMACEUTICALS, INC. (Ba3 CORPORATE FAMILY RATING); NEGATIVE RATING OUTLOOK	Moody's Investors Service
21 Apr 2005	Rating Action	MOODY'S CONFIRMS RATINGS OF KING PHARMACEUTICALS, INC. (Ba3 SR. IMPLIED; Ba2 SR. SECURED CREDIT FACILITY); RATING OUTLOOK NEGATIVE	Moody's Investors Service
01 Dec 2004	Rating Action	MOODY'S DOWNGRADES RATINGS OF KING PHARMACEUTICALS, INC. (Sr. IMPLIED TO Ba3 FROM Ba1); RATINGS REMAIN UNDER REVIEW FOR POSSIBLE DOWNGRADE	Moody's Investors Service
26 Jul 2004	Rating Action	MOODY'S ADJUSTS RATINGS REVIEW OF KING PHARMACEUTICALS, INC., RATINGS NOW UNDER REVIEW WITH DIRECTION UNCERTAIN	Moody's Investors Service
07 May 2004	Rating Action	MOODY'S PLACES RATINGS OF KING PHARMACEUTICALS, INC. UNDER REVIEW FOR POSSIBLE DOWNGRADE	Moody's Investors Service
01 Apr 2004	Financial Statement Ratios	King Pharmaceuticals, Inc.	Moody's Investors Service
11 Feb 2003	Rating Action	MOODY'S CONFIRMS RATINGS OF KING PHARMACEUTICALS' INC.; OUTLOOK CHANGED TO STABLE FROM POSITIVE	Moody's Investors Service
14 Mar 2002	Rating Action	MOODY'S ASSIGNS Baa3 RATING TO KING PHARMACEUTICALS, INC.'S NEW SECURED CREDIT FACILITY; SENIOR IMPLIED RATING OF Ba1 CONFIRMED	Moody's Investors Service
31 Oct 2001	Rating Action	MOODY'S ASSIGNS Ba1 RATING TO KING PHARMACEUTICALS, INC.'S GTD CONV DEBENTURES, AND UPGRADES ITS SECURED CREDIT FACILITY TO Baa3 FROM Ba2, AND ITS SENIOR SUB NOTES TO Ba2 FROM Ba3; RATING OUTLOOK IS POSITIVE	Moody's Investors Service
27 Jul 2001	Rating Action	MOODY'S RE-CALIBRATES ITS PREFERRED STOCK RATING SCALE TO PROMOTE CROSS-SECTOR COMPARABILITY	Moody's Investors Service
19 Jan 2001	Rating Action	MOODY'S UPGRADES RATINGS OF KING PHARMACEUTICALS, INC.'S SECURED CREDIT FACILITY TO Ba2 FROM B1 AND ITS SENIOR SUBORDINATED NOTES TO B1 FROM B3	Moody's Investors Service
08 Feb 1999	Rating Action	MOODY'S ASSIGNS B3 RATING TO KING PHARMACEUTICALS' SENIOR SUBORDINATED NOTES AND RAISES THE RATING OF THE SECURED CREDIT FACILITY FROM B2 TO B1	Moody's Investors Service
28 Dec 1998	Rating Action	MOODY'S ASSIGNS B2 RATING TO KING PHARMACEUTICAL'S SECURED CREDIT FACILITY	Moody's Investors Service

Ergebnisse 1 - 31 von 31

Seite 1 von 1 Next

Research & Ratings

Produkte & Lösungen

News & Events

Registrierter Nutzer

Noch nicht registriert?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: